Use of this website constitutes acceptance of the PlacidWay.com Terms of Use, Privacy Policy, and Cookie Policy.
© Copyright PlacidWay, LLC 2007 - Present. All Rights Reserved
Training and Career:
Clinical Activity:
Prof. Silani coordinates the clinical activity of 12 inpatient beds and 4 Stroke Unit beds of the Neurology Department, taking care of the principal pathologies of the Central and Peripheral Nervous System with particular attention paid to the neurodegenerative and cerebrovascular diseases:Motor Neuron Diseases (Amyotrophic Lateral Sclerosis), Extrapyramidal disorders (Parkinson's disease, Huntington's disease, Parkinsonisms), Dementia (Frontotemporal Dementia, Alzheimer's Disease) and cerebrovascular pathologies are specifically studied. Large clinical databases provide support to an extended collection of DNA, liquor, serum, and skin fibroblasts (BioBank) transformed into stem cells (iPSCs).
Academical Activities:
Prof. Silani is responsible for various University Courses for both Students and Postgraduates of the University of Milan Medical School, as well as in the context of the European Neurological Society (ENS) and the European Federation of Neurological Societies (FENS) with Teaching Courses.??Prof. Silani contributed greatly to the study of neurodegenerative, and more recently, cerebrovascular diseases in the dual clinical and research responsabilities at the Neuroscience Laboratory of the IRCCS Istituto Auxologico Italiano. He has trained new generations of neurologists and neuroscientists over the years based on broad collaborative exchanges with the most prestigious European and North American Institutions. He has also participated in the first MD and PhD training programme of the University of Milan.
Research Work and Publications:
As a Neuroscientist, Prof. Silani has studied Neurodegenerative Diseases and Amyotrophic Lateral Sclerosis (ALS), in particular, from 1977. His contribution to both clinical and basic research work has been significant: after an intensive study of neuronal cells in culture with development of a cryopreservation method for human cells, he then progressively developed an ALS Centre in Milan with a large database for both familial and sporadic cases, supported by a large collection of biological samples.??Prof. Silani was the Principal Investigator (PI) in various clinical trials.
As the Founder of “Consorzio Italiano SLAGEN” (Italian consortium for the genetics of ALS) he has been involved in various genetic research projects concerning ALS (2009 - to the present day), including a broad Genome-Wide Association (GWA) study designed to identify the genetic risk factors associated with susceptibility to the ALS in the sporadic form. He was also PI in an exome sequencing study on Italian pedigrees with familial ALS, sustained by “AriSLA” (ALS Research Agency) (ExomeFALS 2009 Project) and identified two genes of the familial forms of ALS. He is now engaged in identifying de novo mutations by sequencing the exome of patients suffering from ALS and of their parents (NOVALS 2012 Project – AriSLA).
Prof. Silani has also taken a broad interest in Parkinson's Disease, being the co-author of the first grafting in Italy of autologous medullary cells in the brain (1987). He is interested also in Huntington's Disease, contributing with the collaborators to study a large number of families. More recently, he is interested in defining the biological mechanism of neural degeneration in Frontotemporal Dementia (FTLD).?? ??Prof. Silani has recently taken an active part in an international collaborative project to define neuroimaging biomarkers in neurodegenerative pathologies (ALS and FTD) (NiSALS, 2011 - to the present) and collaborated to activate a vast Brain Computer Interface (BCI) project to facilitate the neuropsychological evaluation and the communication of patients suffering from mutation deficiencies, by developing a large Neuropsychology Unit.
Prof. Silani is the author of 220 papers published in international journals, including, Science, Nature, Neuron, Lancet, Lancet Neurology, Annals of Neurology, Neurology and New England Journal of Medicine.
Medical Degree cum laude (1977), ECFMG USA (1980), ?Residency in Neurology (1981) and Neurosurgery (1987) completed both cum laude at the University of Milan Medical School.
Costs of Neurology procedures in Europe | Prices | Enquire |
---|---|---|
Craniotomy in Germany | $9345 | Enquire |
Headaches and Migraines in Ireland | $50 - $67 | Enquire |
Alzheimers disease in Spain | $106 - $12770 | Enquire |
Alzheimers disease in Switzerland | $18500 - $28000 | Enquire |
Craniotomy in Turkey | $101 - $5076 | Enquire |
Encephalitis in United Kingdom | $87 - $354 | Enquire |
I've had two stem cell treatments and will be returning for my third treatment to help with rheumatoid arthritis symptoms. As a nurse, the team is very professional and knowledgeable. The clinic is clean and they follow universal infection control practices. I was initially denied due to my advancement of disease which reassured me that they were not out for money. After crying to the doctor and explaining that I'm not looking for a cure but relief of symptoms, it was a go. I noticed a difference in pain issues ten days after treatment. My second treatment got rid of all the swelling and I lost 15 pounds of fluid. I'm not cured and still have moments but the moments don't last for weeks and months and the pain duration, intensity have greatly been reduced. My husband says that my bad days stand out compared to pre-stem cell treatment when I rarely had a good day. I chose progencell for several reasons and cost was a major factor. This clinic doesn't exploit your finances. I compared five clinics worldwide and found this clinic not only to be the best price, but the integrity of this clinic was outstanding. They listen to you and do everything to ensure your wellbeing remains a priority. They took care of all the details like transportation, hotel etc. The area is very safe and the people are amazing! Placidway was key in finding this clinic and I'm thankful that they provide thousands of options.
Really quick with responses and very professional
No real experience, the site is obscure and ununderstandable. No human lien... a zéro...
Prompt response!